Skip to content

Cognitive behavioral treatment focused on positive memories for post-traumatic stress in intimate partner violence

Post-traumatic stress and intimate partner violence against women: development and evaluation of treatment focused on positive memories

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73702156
Enrollment
135
Registered
2022-03-10
Start date
2021-10-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of posttraumatic stress symptoms in female intimate partner violence survivors Mental and Behavioural Disorders

Interventions

A multigroup design (three groups) with repeated measures will be used, with five levels (pre-treatment, post-treatment and follow-ups at 3, 6 and 12 months) for the experimental groups and two levels

Sponsors

Complutense University of Madrid
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Participants must all be women 2. Participants must be over 18 years old. 3. Participants must be proficient in the use of the Spanish language 4. Participants must be victims of gender-based intimate partner violence. 5. Participants must have endure said violence at least one month before the start of the trial. 6. Participants show absence of suicide risk. Suicide risk is assessed using a Likert-type question in the screening in the last two weeks (item 9 of the Spanish version of the Beck Depression Inventory II – BDI-II; Beck et al., 1996 –). The person will match the criteria for inclusion whenever the answers given are option 0 (“I do not consider committing suicide”) or 1 (“I have thought about committing suicide but I’m not willing to go through with it”). 7. Participants must present PTSD according to DSM-5 criteria. PTSD symptoms and trauma history were assessed using the Global Assessment of Posttraumatic Stress Scale 5 (EGEP-5; in Spanish: Evaluación Global de Estrés Postraumático – 5; Crespo et al., 2017). 8. Participants must have agreed to take part in the study voluntarily.

Exclusion criteria

Exclusion criteria: 1. The participant suffers from physical or mental conditions or has any other limitation (illiteracy, disability, etc) that further complicates her participation in evaluation or treatment sessions. 2. The participant has been diagnosed or suffers from psychotic disorders 3. The participant is currently receiving or has received psychological treatment over the last 6 months.

Design outcomes

Primary

MeasureTime frame
Posttraumatic stress symptoms and PTSD diagnosis are measured using the Global Posttraumatic Stress Evaluation 5 (Evaluación Global de Estrés Postraumático 5 -EGEP-5) (Crespo et al., 2017) at Pre-treatment; Post-treatment assessment: to be performed in the first 14 days, after the last treatment session; Follow-up 3 months; Follow-up 6 months; and Follow-up 12 months.

Secondary

MeasureTime frame
Measured at Pre-treatment; Post-treatment assessment: to be performed in the first 14 days, after the last treatment session; Follow-up 3 months; Follow-up 6 months; and Follow-up 12 months (unless noted otherwise): 1. Level of physical, psychological and sexual violence of intimate partner abuse measured using Conflict Tactics Scales version 2 (CTS2, Loinaz, 2012) 2. Acceptability of intimate partner violence measured using Acceptability of Intimate Partner Violence Against Women short form scale (A-IPVAW-8, Martín-Fernández et al., 2021) 3. Victim-Blaming attitudes measured using Victim-blaming Attitudes in Cases of Intimate Partner Violence against Women Scale Short Form (VB-IPVAW, Martín-Fernández et al., 2018) 4. Meanings associated with trauma measured using Brief Version of The Posttraumatic Cognitions Inventory (PTCI-9; Wells et al., 2019) 5. Self-Concept and Identity measured using Self-Concept and Identity Measure (SCIM; Kaufman et al., 2015) 6. Trauma centrality measured using Centrality of Event Scale (CES; Bernsten & Rubin, 2006) 7. Positive and negative affect measured using Positive and Negative Affect Schedule (PANAS; Watson, et al., 1988) 8. Anxious symptomatology measured using Beck Anxiety Inventory (BAI; Beck et al., 1988) 9. Depressive symptomatology measured using Beck Depression Inventory-II (BDI-II; Beck et al., 1996) 10. Level of self-esteem measured using Rosenberg Self-Esteem Scale (RSE; Rosenberg, 1965) 11. Difficulties in Emotion Regulation measured using Difficulties in Emotion Regulation Scale Short Form (DERS - SF; Kaufman et al, 2016) 12 Difficulties in Positive Emotion Regulation measured using Difficulties in Emotion Regulation Scale–Positive (DERS-P; Weiss, et al., 2015) 13. General health status measured using 12 Item Short Form Health Survey Version 2 (SF-12 v2; Ware et al., 2002) 14. Motivation for change for victims measured using an ad hoc generated questionnaire 15. Satisfaction with treatment measured using Client Satisfac

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026